Covid-19: pharmacotherapeutic insights on various curative approaches in terms of vulnerability, comorbidities, and vaccination

Inflammopharmacology - Tập 30 Số 1 - Trang 1-21 - 2022
Rupinder Kaur1, Simranjeet Singh1, Thakur Gurjeet Singh1, Pragati Sood1, J Desnick Robert1
1Chitkara College of Pharmacy, Chitkara University, Punjab, India

Tóm tắt

Từ khóa


Tài liệu tham khảo

Abdel Massih AF, Mahrous R, Taha A, Saud A, Osman A, Kamel B, Yacoub E, Menshawey E, Ismail HA, Aita L, Dous M (2020) The potential use of ABO blood group system for risk stratification of COVID-19. Med Hypotheses 145:110343. https://doi.org/10.1016/j.mehy.2020.110343

Ad’hiah AH, Abdullah MH, Alsudani MY, Shnawa RM, Al-Sa’ady AJ, Allami RH, Misha’al KI, Jassim IA, Taqi EA (2020) Association between ABO blood groups and susceptibility to COVID-19: profile of age and gender in Iraqi patients. Egypt J Med Hum Genet 21:1

Ahmad T, Rodriguez-Morales AJ (2019) Emergence of COVID-19 (formerly 2019-novel Coronavirus): a new threat from China. Rev Panam Enferm Infecc 2(2):37–38. http://orcid.org/0000-0001-8793-273X

Akkawi AR, Ghazal M (2021) COVID-19 and cardiac arrhythmias: a review of the literature. Cureus. https://doi.org/10.7759/cureus.17797

Al-Ani S, Chehade S, Lazo-Langner A (2020) Thrombosis risk associated with COVID-19 infection. A scoping review. Thromb Res 192:152–160. https://doi.org/10.1016/j.thromres.2020.05.039

Al-Sadeq DW, Nasrallah GK (2020) The incidence of the novel coronavirus SARS-CoV-2 among asymptomatic patients: a systematic review. Int J Infect Dis 98:372–380

Alqahtani JS, Oyelade T, Aldhahir AM, Alghamdi SM, Almehmadi M, Alqahtani AS, Hurst JR (2020) Prevalence, severity and mortality associated with COPD and smoking in patients with COVID-19: a rapid systematic review and meta-analysis. PLoS One 15:e0233147. https://doi.org/10.1371/journal.pone.0233147

Antonucci M, Recupero SM, Marzio V, De Dominicis M, Pinto F, Foschi N, Di Gianfrancesco L, Bassi P, Ragonese M (2020) The impact of COVID-19 outbreak on urolithiasis emergency department admissions, hospitalizations and clinical management in central Italy: a multicentric analysis. Actas Urol Esp 44:611–616. https://doi.org/10.1016/j.acuroe.2020.10.006 (English Edition)

Apicella M, Campopiano MC, Mantuano M, Mazoni L, Coppelli A, Del Prato S (2020) COVID-19 in people with diabetes: understanding the reasons for worse outcomes. Lancet Diabetes Endocrinol. https://doi.org/10.1016/S2213-8587(20)30238-2

Aw D, Silva AB, Palmer DB (2007) Immunosenescence: emerging challenges for an ageing population. Immunology 120:435–446. https://doi.org/10.1111/j.1365-2567.2007.02555.x

Babapoor-Farrokhran S, Gill D, Walker J, Rasekhi RT, Bozorgnia B, Amanullah A (2020) Myocardial injury and COVID-19: possible mechanisms. Life Sci 253:117723. https://doi.org/10.1016/j.lfs.2020.117723

Baille G, Chenivesse C, Perez T, Machuron F, Dujardin K, Devos D, Moreau C (2019) Dyspnea: an underestimated symptom in Parkinson’s disease. Parkinsonism RelatDisord 60:162–166. https://doi.org/10.1016/j.parkreldis.2018.09.001

Balakrishnan VS (2020) The arrival of Sputnik V. Lancet Infect Dis 20:1128. https://doi.org/10.1016/S1473-3099(20)30709-X

Baldi E, Sechi GM, Mare C, Canevari F, Brancaglione A, Primi R, Klersy C, Palo A, Contri E, Ronchi V, Beretta G (2020) Out-of-hospital cardiac arrest during the Covid-19 outbreak in Italy. N Engl J Med 383:496–498. https://doi.org/10.1056/NEJMc2010418

Banerjee AB, Singh TG, Prashar A (2021) BCG vaccine, a ray of hope in treating Severe Acute Respiratory Syndrome (SARS). Infect Disord Drug Targets 21(5):e270421186935. https://doi.org/10.2174/1871526520666201016150501

Bansal M (2020) Cardiovascular disease and COVID-19. Diabetes Metab Syndr: Clin Res Rev 14:247–250. https://doi.org/10.1016/j.dsx.2020.03.013

Bassetti M, Corcione S, Dettori S, Lombardi A, Lupia T, Vena A, De Rosa FG, Gori A, Giacobbe DR (2021) Antiviral treatment selection for SARS-CoV-2 pneumonia. Expert Rev Respir Med 22:1–8. https://doi.org/10.1080/17476348.2021.1927719

Bautista-Vargas M, Bonilla-Abadía F, Cañas CA (2020) Potential role for tissue factor in the pathogenesis of hypercoagulability associated with in COVID-19. J Thromb Thrombolysis 50:479–483. https://doi.org/10.1007/s11239-020-02172-x

Bhatla A, Mayer MM, Adusumalli S, Hyman MC, Oh E, Tierney A, Deo R (2020) COVID-19 and cardiac arrhythmias. Heart Rhythm 17:1439–1444. https://doi.org/10.1016/j.hrthm.2020.06.016

Bloem BR, Trenkwalder C, Sanchez-Ferro A, Kalia LV, Alcalay R, Chiang HL, Kang UJ, Goetz C, Brundin P, Papa SM (2021) COVID-19 vaccination for persons with Parkinson’s disease: light at the end of the tunnel? Parkinson’s Dis 28:1–5. https://doi.org/10.3233/JPD-212573

Boika AV (2020) A post-COVID-19 Parkinsonism in the future? J Mov Disord. https://doi.org/10.1002/mds.28117

Bonsignore MR, Baiamonte P, Mazzuca E, Castrogiovanni A, Marrone O (2019) Obstructive sleep apnea and comorbidities: a dangerous liaison. Multidiscip Respir Med 14:1–12. https://doi.org/10.1186/s40248-019-0172-9

Cetinkaya EA (2020) Coincidence of COVID-19 infection and smell—taste perception disorders. J Craniofac Surg. https://doi.org/10.1097/SCS.0000000000006601

Chen PL, Lee NY, Cia CT, Ko WC, Hsueh PR (2020) A review of treatment of coronavirus disease 2019 (COVID-19): therapeutic repurposing and unmet clinical needs. Front Pharmacol. https://doi.org/10.3389/fphar.2020.584956

Chung JY, Thone MN, Kwon YJ (2021) COVID-19 vaccines: the status and perspectives in delivery points of view. Adv Drug Deliv Rev 170:1–25. https://doi.org/10.1016/j.addr.2020.12.011

Clerkin KJ, Fried JA, Raikhelkar J, Sayer G, Griffin JM, Masoumi A, Uriel N (2020) COVID-19 and cardiovascular disease. Circulation 141:1648–1655. https://doi.org/10.1161/CIRCULATIONAHA.120.046941

Cook TM (2020) The importance of hypertension as a risk factor for severe illness and mortality in COVID-19. Anaesthesia 75:976. https://doi.org/10.1111/anae.15103

Coromilas EJ, Kochav S, Goldenthal I, Biviano A, Garan H, Goldbarg S, Kim JH, Yeo I, Tracy C, Ayanian S, Akar J (2021) Worldwide survey of COVID-19—associated arrhythmias. Circ: Arrhythm Electrophysiol 14:e009458. https://doi.org/10.1161/CIRCEP.120.008719

Cristelo C, Azevedo C, Marques JM, Nunes R, Sarmento B (2020) SARS-CoV-2 and diabetes: new challenges for the disease. Diabetes Res Clin Pract 164:108228. https://doi.org/10.1016/j.diabres.2020.108228

Cui S, Chen S, Li X, Liu S, Wang F (2020) Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J Thromb Haemost 18(6):1421–1424. https://doi.org/10.1111/jth.14830

Cui J, Li F, Shi ZL (2019) Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol 17(3):181–192. https://doi.org/10.1038/s41579-018-0118-9

Cui X, Zhao Z, Zhang T, Guo W, Guo W, Zheng J, Zhang J, Dong C, Na R, Zheng L, Li W, Liu Z, Ma J, Wang J, He S, Xu Y, Si P, Shen Y, Cai C (2021) A systematic review and meta-analysis of children with coronavirus disease 2019 (COVID-19). J Med Virol 93:1057–1069. https://doi.org/10.1002/jmv.26398

Cure E, Cure MC (2020) Comment on “Hearing loss and COVID-19: a note.” Am J Otolaryngol 41:102513. https://doi.org/10.1016/j.amjoto.2020.102513

Dash GC, Subhadra S, Turuk J, Parai D, Rath S, Sabat J, Rout UK, Kanungo S, Choudhary HR, Nanda RR, Pattnaik M, Pati S, Bhattacharya D (2021) Breakthrough SARS-CoV-2 infections among BBV-152 (COVAXIN®) and AZD1222 (COVISHIELDTM ) recipients: report from eastern state of India. J Med Virol. https://doi.org/10.1002/jmv.27382

De Siqueira JV, Almeida LG, Zica BO, Brum IB, Barceló A, de Siqueira Galil AG (2020) Impact of obesity on hospitalizations and mortality, due to COVID-19: a systematic review. Obes Res Clin Pract 14(5):398–403. https://doi.org/10.1016/j.orcp.2020.07.005

Deepika AS, Kaur R, Singh TG, Singh M, Satija S, Singh R (2019) Prescribing pattern of antihypertensive drugs in a tertiary care hospital: a review. Plant Arch 19(2):1311–1316

Di Gennaro F, Pizzol D, Marotta C, Antunes M, Racalbuto V, Veronese N, Smith L (2020) Coronavirus diseases (COVID-19) current status and future perspectives: a narrative review. Int J Environ Res Public Health 17:2690. https://doi.org/10.3390/ijerph17082690

Ding H, Dhima K, Lockhart KC, Locascio JJ, Hoesing AN, Duong K, Trisini-Lipsanopoulos A, Hayes MT, Sohur US, Wills A-M, Mollenhauer B, Flaherty AW, Hung AY, Mejia N, Khurana V, Gomperts SN, Selkoe DJ, Schwarzschild MA, Schlossmacher MG, Hyman BT, Sudarsky LR, Growdon JH, Scherzer CR (2013) Unrecognized vitamin D3 deficiency is common in Parkinson disease: Harvard biomarker study. Neurology 81:1531–1537. https://doi.org/10.1212/wnl.0b013e3182a95818

Donnelly CA, Ghani AC, Leung GM, Hedley AJ, Fraser C, Riley S, Anderson RM (2003) Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong. The Lancet 361:1761–1766. https://doi.org/10.1016/S0140-6736(03)13410-1

Driggin E, Madhavan MV, Bikdeli B, Chuich T, Laracy J, Biondi-Zoccai G, Parikh SA (2020) Cardiovascular considerations for patients, health care workers, and health systems during the COVID-19 pandemic. J Am Coll Cardiol 75:2352–2371. https://doi.org/10.1016/j.jacc.2020.03.031

Fang L, Karakiulakis G, Roth M (2020) Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med 8:e21. https://doi.org/10.1016/S2213-2600(20)30116-8

Fearon C, Fasano A (2021) Parkinson’s disease and the COVID-19 pandemic. J Parkinsons Dis. https://doi.org/10.3233/JPD-202320 (Preprint)

Fernandez C, Rysä J, Almgren P, Nilsson J, Engström G, Orho-Melander M, Melander O (2018) Plasma levels of the proprotein convertase furin and incidence of diabetes and mortality. J Intern Med 284:377–387. https://doi.org/10.1111/joim.12783

Fletcher-Sandersjöö A, Bellander BM (2020) Is COVID-19 associated thrombosis caused by overactivation of the complement cascade? A literature review. Thromb Res 194:36–41. https://doi.org/10.1016/j.thromres.2020.06.027

Gérard C, Maggipinto G, Minon JM (2020) COVID-19 and ABO blood group: another viewpoint. Br J Haematol 190:e93–e94. https://doi.org/10.1111/bjh.16884

Giovanetti M, Benedetti F, Campisi G, Ciccozzi A, Fabris S, Ceccarelli G, Tambone V, Caruso A, Angeletti S, Zella D, Ciccozzi M (2021) Evolution patterns of SARS-CoV-2: snapshot on its genome variants. BiochemBiophys Res Commun 538:88–91. https://doi.org/10.1016/j.bbrc.2020.10.102

Gómez CA, Sun CK, Tsai I, Chang YP, Lin MC, Hung IY, Hung KC (2021) Mortality and risk factors associated with pulmonary embolism in coronavirus disease 2019 patients: a systematic review and meta-analysis. Sci Rep 11:1–13. https://doi.org/10.1038/s41598-021-95512-7

Gopinathannair R, Merchant FM, Lakkireddy DR, Etheridge SP, Feigofsky S, Han JK, Russo AM (2020) COVID-19 and cardiac arrhythmias: a global perspective on arrhythmia characteristics and management strategies. J Interv Card Electrophysiol 59:329–336. https://doi.org/10.1007/s10840-020-00789-9

Grewal AK, Singh N, Singh TG (2019) Effects of resveratrol postconditioning on cerebral ischemia in mice: role of the sirtuin-1 pathway. Can J Physiol Pharmacol 97(11):1094–1101. https://doi.org/10.1139/cjpp-2019-0188 (Epub 2019 Jul 24 PMID: 31340128)

Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE (2020) Extrapulmonary manifestations of COVID-19. Nat Med 26:1017–1032. https://doi.org/10.1038/s41591-020-0968-3

Guzik TJ, Mohiddin SA, Dimarco A, Patel V, Savvatis K, Marelli-Berg FM, McInnes IB (2020) COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. Cardiovasc Res 116:1666–1687. https://doi.org/10.1093/cvr/cvaa106

Han AY, Mukdad L, Long JL, Lopez IA (2020) Anosmia in COVID-19: mechanisms and significance. Chem Senses 45:423–428

Hanff TC, Mohareb AM, Giri J, Cohen JB, Chirinos JA (2020) Thrombosis in COVID-19. Am J Hematol 95:1578–1589. https://doi.org/10.1002/ajh.25982

Harenberg J, Jonas JB, Trecca EM (2020) A liaison between sudden sensorineural hearing loss and SARS-CoV-2 infection. Thromb Haemost 120:1237–1239. https://doi.org/10.1055/s-0040-1714370

Harikrishnan P (2020) Gustatory dysfunction as an early symptom in COVID-19 screening. J Craniofac Surg. https://doi.org/10.1097/SCS.0000000000006797

Heurich A, Hofmann-Winkler H, Gierer S, Liepold T, Jahn O, Pöhlmann S (2014) TMPRSS2 and ADAM17 cleave ACE2 differentially and only proteolysis by TMPRSS2 augments entry driven by the severe acute respiratory syndrome coronavirus spike protein. J Virol 88:1293–1307. https://doi.org/10.1128/JVI.02202-13

Ho JC, Chan KN, Hu WH, Lam WK, Zheng L, Tipoe GL, Tsang KW (2001) The effect of aging on nasal mucociliary clearance, beat frequency, and ultrastructure of respiratory cilia. Am J Respir Crit Care Med 163:983–988. https://doi.org/10.1164/ajrccm.163.4.9909121

Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu NH, Nitsche A, Müller MA (2020) SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181:271–280. https://doi.org/10.1016/j.cell.2020.02.052

Hribar CA, Cobbold PH, Church FC (2020) Potential role of vitamin D in the elderly to resist COVID-19 and to slow progression of Parkinson’s disease. Brain Sci 10:284. https://doi.org/10.3390/brainsci10050284

Hung IF, Yuen KY (2020) Early triple antiviral therapy for COVID-19–Authors’ reply. The Lancet 396:1488. https://doi.org/10.1016/S0140-6736(20)32268-6

Ilie PC, Stefanescu S, Smith L (2020) The role of vitamin D in the prevention of coronavirus disease 2019 infection and mortality. Aging Clin Exp Res 32:1195–1198. https://doi.org/10.1007/s40520-020-01570-8

Indari O, Jakhmola S, Manivannan E, Jha HC (2021) An update on antiviral therapy against SARS-CoV-2: how far have we come? Front Pharmacol 12:133. https://doi.org/10.3389/fphar.2021.632677

Ji T, Liu Z, Wang G, Guo X, Lai C, Chen H, Zhou Q (2020) Detection of COVID-19: A review of the current literature and future perspectives. Biosens Bioelectron 166:112455. https://doi.org/10.1016/j.bios.2020.112455

Kahn JS, McIntosh K (2005) History and recent advances in coronavirus discovery. Pediatr Infect Dis J 24:S223–S227. https://doi.org/10.1097/01.inf.0000188166.17324.60

Kanwal A, Agarwala A, Martin LW, Handberg EM, Yang E (2020) COVID-19 and hypertension: what we know and don't know. Am Coll Cardiol

Khan A (2018) Prevalence, pathophysiological mechanisms and factors affecting urolithiasis. Int Urol Nephrol 50:799–806. https://doi.org/10.1007/s11255-018-1849-2

Kochav SM, Coromilas E, Nalbandian A, Ranard LS, Gupta A, Chung MK (2020) Cardiac arrhythmias in COVID-19 infection. Circ Arrhythm Electrophysiol 13:e008719

Koyama RG, Drager LF, Lorenzi-Filho G, Cintra FD, Pereira AC, Poyares D, Pedrazzoli M (2009) Reciprocal interactions of obstructive sleep apnea and hypertension associated with ACE I/D polymorphism in males. Sleep Med 10:1107–1111. https://doi.org/10.1016/j.sleep.2008.12.012

Koyama T, Platt D, Parida L (2020) Variant analysis of SARS-CoV-2 genomes. Bull World Health Organ 98:495–504. https://doi.org/10.2471/BLT.20.253591

Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR (2020) Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges. Int J Antimicrob Agents 55:105924. https://doi.org/10.1016/j.ijantimicag.2020.105924

Latz CA, DeCarlo C, Boitano L, Png CM, Patell R, Conrad MF, Eagleton M, Dua A (2020) Blood type and outcomes in patients with COVID-19. Ann Hematol 99:2113–2118. https://doi.org/10.1007/s00277-020-04169-1

Lee Y, Min P, Lee S, Kim SW (2020) Prevalence and duration of acute loss of smell or taste in COVID-19 patients. J Korean Med Sci. https://doi.org/10.3346/jkms.2020.35.e174

Lim S, Bae JH, Kwon HS, Nauck MA (2021) COVID-19 and diabetes mellitus: from pathophysiology to clinical management. Nat Rev Endocrinol 17(1):11–30. https://doi.org/10.1038/s41574-020-00435-4

Liu K, Fang YY, Deng Y, Liu W, Wang MF, Ma JP, Liu HG (2020) Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province. Chin Med J 133:1025. https://doi.org/10.1097/CM9.0000000000000744

Long B, Brady WJ, Koyfman A, Gottlieb M (2020) Cardiovascular complications in COVID-19. Am J Emerg Med 38:1504–1507. https://doi.org/10.1016/j.ajem.2020.04.048

Longobardi L, Di Giorgio A, Perrotta F, Costigliola A, Cerqua FS, Cioffi G, Stefanelli F (2016) Bronchial asthma in the elderly patient. J Gerontol Geriatr 64:55–65

Maas MB, Kim M, Malkani RG, Abbott SM, Zee PC (2020) Obstructive sleep apnea and risk of COVID-19 infection, hospitalization and respiratory failure. Sleep Breath 29:1–3. https://doi.org/10.1007/s11325-020-02203-0

Mahase E (2020) Covid-19: moderna applies for US and EU approval as vaccine trial reports 94.1% efficacy. BMJ 371:m4709. https://doi.org/10.1136/bmj.m4709

Manolis AS, Manolis AA, Manolis TA, Apostolopoulos EJ, Papatheou D, Melita H (2020) COVID-19 infection and cardiac arrhythmias. Trends Cardiovasc Med. https://doi.org/10.1016/j.tcm.2020.08.002

Marshall M (2021) COVID’s toll on smell and taste: what scientists do and don’t know. Nature 589:342–343

Miller MA, Cappuccio FP (2020) A systematic review of COVID-19 and obstructive sleep apnoea. Sleep Med Rev 8:101382. https://doi.org/10.1016/j.smrv.2020.101382

Mitchell F (2020) Vitamin-D and COVID-19: do deficient risk a poorer outcome? Lancet Diabetes Endocrinol 8:570. https://doi.org/10.1016/S2213-8587(20)30183-2

Mustafa MW (2020) Audiological profile of asymptomatic Covid-19 PCR-positive cases. Am J Otolaryngol 41:102483. https://doi.org/10.1016/j.amjoto.2020.102483

Nagashima K, Wege H, Meyermann R, Ter Meulen V (1978) Corona virus induced subacute demyelinating encephalomyelitis in rats: a morphological analysis. Acta Neuropathol 44:63–70. https://doi.org/10.1007/BF00691641

Ni W, Yang X, Yang D, Bao J, Li R, Xiao Y, Gao Z (2020) Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19. J Crit Care 24:1–10. https://doi.org/10.1186/s13054-020-03120-0

Nishiga M, Wang DW, Han Y, Lewis DB, Wu JC (2020) COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives. Nat Rev Cardiol 17:543–558. https://doi.org/10.1038/s41569-020-0413-9

Page EM, Ariëns RA (2021) Mechanisms of thrombosis and cardiovascular complications in COVID-19. Thromb Res 200:1–8. https://doi.org/10.1016/j.thromres.2021.01.005

Pal M, Berhanu G, Desalegn C, Kandi V (2020) Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): an update. Cureus. https://doi.org/10.7759/cureus.7423

Paramasivam A, Priyadharsini JV, Raghunandhakumar S, Elumalai P (2020) A novel COVID-19 and its effects on cardiovascular disease. Hypertens Res 43:729–730. https://doi.org/10.1038/s41440-020-0461-x

Peng L, Shen L, Xu J, Tian X, Liu F, Wang J, Tian G, Yang J, Zhou L (2021) Prioritizing antiviral drugs against SARS-CoV-2 by integrating viral complete genome sequences and drug chemical structures. Sci Rep 11:1–1. https://doi.org/10.1038/s41598-021-83737-5

Petersen E, Koopmans M, Go U, Hamer DH, Petrosillo N, Castelli F, Simonsen L (2020) Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics. Lancet Infect Dis. https://doi.org/10.1016/S1473-3099(20)30484-9

Raheem AA, Alowidah I, Soliman M, Haresy M, Almozeni A, Althagafi S, Almousa M, Alturki M (2020) Urolithiasis treatment options during COVID-19 pandemic: review of current recommendations and triage systems. Afr J Urol 26:1–7. https://doi.org/10.1186/s12301-020-00085-y

Rehman M, Gondal A, Rehman NU (2020) Atypical manifestation of COVID-19-induced myocarditis. Cureus. https://doi.org/10.7759/cureus.8685

Rostami M, Mansouritorghabeh H (2020) D-dimer level in COVID-19 infection: a systematic review. Expert Rev Hematol 13:1265–1275. https://doi.org/10.1080/17474086.2020.1831383

Rubin EJ, Longo DL (2020) SARS-CoV-2 Vaccination—an ounce (actually, much less) of prevention. N Engl J Med 383:2677–2678. https://doi.org/10.1056/NEJMe2034717

Salles-Gándara P, Rojas-Fernandez A, Salinas-Rebolledo C, Milan-Sole A (2020) The potential role of SARS-COV-2 in the pathogenesis of Parkinson’s disease. Front Neurol 11:1044. https://doi.org/10.3389/fneur.2020.01044

Samudrala PK, Kumar P, Choudhary K, Thakur N, Wadekar GS, Dayaramani R, Alexander A (2020) Virology, pathogenesis, diagnosis and in-line treatment of COVID-19. Eur J Pharmacol 883:173375. https://doi.org/10.1016/j.ejphar.2020.173375

Saniasiaya J (2021) Hearing loss in SARS-CoV-2: what do we know? Ear Nose Throat J 100:152S-154S. https://doi.org/10.1177/0145561320946902

Santesmasses D, Castro JP, Zenin AA, Shindyapina AV, Gerashchenko MV, Zhang B, Gladyshev VN (2020) COVID-19 is an emergent disease of aging. Aging Cell 19:e13230. https://doi.org/10.1111/acel.13230

Sanyaolu A, Okorie C, Marinkovic A, Patidar R, Younis K, Desai P, Altaf M (2020) Comorbidity and its impact on patients with COVID-19. SN Compr Clin Med. https://doi.org/10.1007/s42399-020-00363-4

Scorza FA, Fiorini AC, Scorza CA, Finsterer J (2018) Cardiac abnormalities in Parkinson’s disease and Parkinsonism. J ClinNeurosci 53:1–5. https://doi.org/10.1016/j.jocn.2018.04.031

Sharma VK, Singh TG (2020a) Chronic stress and diabetes mellitus: interwoven pathologies. Curr Diabetes Rev 16(6):546–556. https://doi.org/10.2174/1573399815666191111152248 (PMID: 31713487)

Sharma VK, Singh TG (2020b) Insulin resistance and bioenergetic manifestations: targets and approaches in Alzheimer’s disease. Life Sci 262:118401. https://doi.org/10.1016/j.lfs.2020.118401 (Epub 2020 Sep 12 PMID: 32926928)

Sharma VK, Singh TG (2020c) Navigating Alzheimer’s disease via chronic stress: the role of glucocorticoids. Curr Drug Targets 21(5):433–444. https://doi.org/10.2174/1389450120666191017114735 (PMID: 31625472)

Sharma A, Khan H, Singh TG, Grewal AK, Najda A, Kawecka-Radomska M, Kamel M, Altyar AE, Del-Daim MM (2021a) Pharmacological modulation of ubiquitin-proteasome pathways in oncogenic signaling. Int J Mol Sci 22(21):11971. https://doi.org/10.3390/ijms222111971 (PMID:34769401;PMCID:PMC8584958)

Sharma T, Kaur D, Grewal AK, Singh TG (2021b) Therapies modulating insulin resistance in Parkinson’s disease: a cross talk. Neurosci Lett 749:135754. https://doi.org/10.1016/j.neulet.2021.135754 (Epub 2021 Feb 18 PMID: 33610666)

Sher L (2020) COVID-19, anxiety, sleep disturbances and suicide. Sleep Med 70:124. https://doi.org/10.1016/j.sleep.2020.04.019

Silveira MM, Moreira GMSG, Mendonça M (2021) DNA vaccines against COVID-19: perspectives and challenges. Life Sci 267:118919. https://doi.org/10.1016/j.lfs.2020.118919

Simonnet A, Chetboun M, Poissy J, Raverdy V, Noulette J, Duhamel A, Verkindt H (2020) High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation. Obesity 28:1195–1199. https://doi.org/10.1002/oby.22831

Singh S, Singh TG (2020) Role of nuclear factor Kappa B (NF-κB) signalling in neurodegenerative diseases: an mechanistic approach. Curr Neuropharmacol 18(10):918–935. https://doi.org/10.2174/1570159X18666200207120949.PMID:32031074;PMCID:PMC7709146

Singh AK, Gupta R, Ghosh A, Misra A (2020a) Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations. Diabetes Metab Syndr: Clin Res Rev 14:303–310. https://doi.org/10.1016/j.dsx.2020.04.004

Singh R, Rao HK, Singh TG (2020b) Advanced glycated end products (ages) in diabetes and its complications: an insight. Plant Arch 20(1):3838–3841

Singh TG, Sharma R, Kaur A, Dhiman S, Singh R (2020c) Evaluation of renoprotective potential of Ficus religiosa in attenuation of diabetic nephropathy in rats. Obes Med 19:100268

Singh R, Rao HK, Singh TG (2021) Comparison of safety and efficacy of pregabalin, duloxetine and their combination with epalrestat in diabetic neuropathy: a prospective, double-blind, randomized, controlled Trial. J Appl Pharm Sci 11:071–079

Smetanová J, Střížová Z, Bartůňková J, Milota T (2020) Principles and new perspectives in the vaccination against SARS-CoV-2 virus. Cas Lek Cesk 159:298–302

Soleimanpour S, Yaghoubi A (2021) COVID-19 vaccine: where are we now and where should we go? Expert Rev Vaccines 20:23–44. https://doi.org/10.1080/14760584.2021.1875824

Sorbera C, Brigandì A, Cimino V, Bonanno L, Ciurleo R, Bramanti P, Marino S (2021) The impact of SARS-COV2 infection on people in residential care with Parkinson Disease or parkinsonisms: clinical case series study. PLoS One 16:e0251313. https://doi.org/10.1371/journal.pone.0251313

South AM, Diz DI, Chappell MC (2020) COVID-19, ACE2, and the cardiovascular consequences. Am J Physiol Heart Circ Physiol 318:H1084–H1090. https://doi.org/10.1152/ajpheart.00217.2020

Srivastava K (2020) Association between COVID-19 and cardiovascular disease. Int J Cardiol Heart Vasc. https://doi.org/10.1016/j.ijcha.2020.100583

Sriwijitalai W, Wiwanitkit V (2020) Hearing loss and COVID-19: a note. Am J Otolaryngol. https://doi.org/10.1016/j.amjoto.2020.102473

Subramaniam A, Elsayed RM (2021) Does obesity increase the morbidity and mortality in COVID-19 patients. evidence based clinical review. Sch J App Med Sci 2:248–252. https://doi.org/10.36347/sjams.2021.v09i02.014

Sulzer D, Antonini A, Leta V, Nordvig A, Smeyne RJ, Goldman JE, Al-Dalahmah O, Zecca L, Sette A, Bubacco L, Meucci O (2020) COVID-19 and possible links with Parkinson’s disease and parkinsonism: from bench to bedside. NPJ Parkinsons Dis 6:1. https://doi.org/10.1038/s41531-020-00123-0

Syed MA, Al Nuaimi AS, Nasrallah GK, Althani AA, Yassine HM, Zainel A, AAbdulmalik MA (2021) Epidemiology of SARS-CoV2 in Qatar’s primary care population aged 10 years and above. BMC Infect Dis 21:1–11. https://doi.org/10.1186/s12879-021-06251-z

Tadic M, Cuspidi C, Mancia G, Dell’Oro R, Grassi G (2020) COVID-19, hypertension and cardiovascular diseases: should we change the therapy? Pharmacol Res Commun 158:104906. https://doi.org/10.1016/j.phrs.2020.104906

Tanaka SI, Isoda F, Ishihara Y, Kimura M, Yamakawa T (2001) T lymphopaenia in relation to body mass index and TNF-α in human obesity: adequate weight reduction can be corrective. Clin Endocrinol 54:347–354. https://doi.org/10.1046/j.1365-2265.2001.1139cn2155.x

Tang JW, Tambyah PA, Hui DS (2021) Emergence of a new SARS-CoV-2 variant in the UK. J Infect 82:e27–e28. https://doi.org/10.1016/j.jinf.2020.12.024

Tefik T, Guven S, Villa L, Gokce MI, Kallidonis P, Petkova K, Kiremit MC, Sonmez MG, De Lorenzis E, Eryildirim B, Sarica K (2020) Urolithiasis practice patterns following the COVID-19 pandemic: overview from the EULIS collaborative research working group. Eur Urol Suppl. https://doi.org/10.1016/j.eururo.2020.04.057

Thapa K, Verma N, Singh TG, Kaur Grewal A, Kanojia N, Rani L (2021) COVID-19-associated acute respiratory distress syndrome (CARDS): mechanistic insights on therapeutic intervention and emerging trends. Int Immunopharmacol 101(Pt A):108328. https://doi.org/10.1016/j.intimp.2021.108328

Tison GH, Avram R, Kuhar P, Abreau S, Marcus GM, Pletcher MJ, Olgin JE (2020) Worldwide effect of COVID-19 on physical activity: a descriptive study. Ann Intern Med 173:767–770. https://doi.org/10.7326/M20-2665

Tomasoni D, Italia L, Adamo M, Inciardi RM, Lombardi CM, Solomo SD, Metra M (2020) COVID-19 and heart failure: from infection to inflammation and angiotensin II stimulation. Searching for evidence from a new disease. Eur J Heart Fail 22:957–966. https://doi.org/10.1002/ejhf.1871

Trecca EMC, Gelardi M, Cassano M (2020) COVID-19 and hearing difficulties. Am J Otolaryngol 41:102496. https://doi.org/10.1016/j.amjoto.2020.102496

Tsatsakis A, Calina D, Falzone L, Petrakis D, Mitrut R, Siokas V, Docea AO (2020) SARS-CoV-2 pathophysiology and its clinical implications: an integrative overview of the pharmacotherapeutic management of COVID-19. Food ChemToxicol 146:111769. https://doi.org/10.1016/j.fct.2020.111769

Türk C, Petřík A, Sarica K, Seitz C, Skolarikos A, Straub M, Knoll T (2016) EAU guidelines on diagnosis and conservative management of urolithiasis. Eur Urol 69(Suppl.1):468–474. https://doi.org/10.1016/j.eururo.2015.07.040

Unudurthi SD, Luthra P, Bose RJ, McCarthy J, Kontaridis MI (2020) Cardiac inflammation in COVID-19: lessons from heart failure. Life Sci. https://doi.org/10.1016/j.lfs.2020.118482

Van Nieuwkoop C (2020) COVID-19 associated pulmonary thrombosis. Thromb Res 191:151. https://doi.org/10.1016/j.thromres.2020.04.042

Vellingiri B, Jayaramayya K, Iyer M, Narayanasamy A, Govindasamy V, Giridharan B, Subramaniam MD (2020) COVID-19: a promising cure for the global panic. Sci Total Environ 725:138277. https://doi.org/10.1016/j.scitotenv.2020.138277

Vishwakarma S, Singh S, Singh TG (2021) Pharmacological modulation of cytokines correlating neuroinflammatory cascades in epileptogenesis. Mol Biol Rep. https://doi.org/10.1007/s11033-021-06896-8 (Epub ahead of print. PMID: 34751915)

Walls AC, Park YJ, Tortorici MA, Wall A, McGuire AT, Veesler D (2020) Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell 181:281–292. https://doi.org/10.1016/j.cell.2020.02.058

Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Peng Z (2020) Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA 323:1061–1069. https://doi.org/10.1001/jama.2020.1585

Wenzel P, Kopp S, Göbel S, Jansen T, Geyer M, Hahn F, Münzel T (2020) Evidence of SARS-CoV-2 mRNA in endomyocardial biopsies of patients with clinically suspected myocarditis tested negative for COVID-19 in nasopharyngeal swab. Cardiovasc Res 116:1661–1663. https://doi.org/10.1093/cvr/cvaa160

www.Clinicaltrials.gov.in

Yavuz S, Ünal S (2020) Antiviral treatment of COVID-19. Turk J Med Sci 21(50):611–619

Zheng YY, Ma YT, Zhang JY, Xie X (2020a) COVID-19 and the cardiovascular system. Nat Rev Cardiol 17:259–260. https://doi.org/10.1038/s41569-020-0360-5

Zheng Z, Peng F, Xu B, Zhao J, Liu H, Peng J, Tang W (2020b) Risk factors of critical & mortal COVID-19 cases: a systematic literature review and meta-analysis. J Infect 81:e16–e25. https://doi.org/10.1016/j.jinf.2020.04.021

Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Cao B (2020) Clinical course and risk factors for mortality of adult in patients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet 395:1054–1062. https://doi.org/10.1016/S0140-6736(20)30566-3